Morning Movers 7/16: LSBX, ARNA, AVII Higher; VVUS, JST, VRNM, BIOF, VIDE, PLCM Lower
VIVUS, Inc. (Nasdaq: VVUS) 56.4% LOWER; today announced that the Endocrinologic and Metabolic Drugs Advisory Committee of the U.S. FDA voted against the following question: "Based on the current available data, do you believe the overall benefit-risk assessment of PHEN/TPM (QNEXA) is favorable to support its approval for the treatment of obesity...
Get Alerted When News Hits On This Stock - FREE!

